Skip to main content

Table 6 Comparison of outcome measurements between patients who received Dangguixu-san and those who received placebo for grade II acute lateral ankle sprain(n = 23)

From: Effects of Dangguixu-san in patients with acute lateral ankle sprain: a randomized controlled trial

Dependent variables Group (n) Week 0 (M ± SD) Week 1 (M ± SD) Week 5 (M ± SD) Difference (w1–w0) Z (p)a Difference (w5–w0) Z (p)a Difference (w5–w1) Z (p)a
VAS of pain DS (n = 11) 50.91 ± 18.14 30.91 ± 22.56 8.45 ± 5.65 −20.00 ± 27.93 − 0.71 (0.479) − 42.45 ± 18.38 − 1.54 (0.123) − 22.45 ± 19.54 − 3.03 (0.002)
Placebo (n = 12) 44.17 ± 11.65 16.00 ± 15.47 15.00 ± 15.08 − 28.17 ± 9.93 −29.17 ± 13.11 −1.00 ± 11.65
Degree of edema DS (n = 11) 1.36 ± 1.03 0.27 ± 0.47 0.36 ± 0.50 − 0.95 ± 1.10 − 1.31 (0.189) − 0.98 ± 0.83 − 0.85 (0.396) 0.03 ± 0.51 − 0.72 (0.473)
Placebo (n = 12) 1.08 ± 0.79 0.50 ± 0.67 0.25 ± 0.62 − 0.41 ± 0.67 − 0.68 ± 0.86 −0.28 ± 0.81
TOTAL
EQ-5D-5L
DS (n = 11) 11.73 ± 3.72 9.73 ± 3.35 5.82 ± 0.75 − 2.00 ± 3.49 − 0.88 (0.880) − 5.91 ± 3.59 − 1.85 (0.065) − 3.91 ± 2.88 − 2.66 (0.008)
Placebo (n = 12) 9.67 ± 2.31 7.50 ± 2.15 6.17 ± 1.40 − 2.17 ± 1.40 − 3.50 ± 1.68 −1.33 ± 1.61
TOTAL
FAOS
DS (n = 11) 261.77 ± 79.97 341.45 ± 88.16 459.39 ± 40.28 79.67 ± 88.48 − 0.31 (0.758) 197.62 ± 71.97 − 1.23 (0.218) 117.95 ± 62.34 − 2.59 (0.010)
Placebo (n = 12) 286.15 ± 64.35 389.86 ± 72.46 443.85 ± 52.68 103.71 ± 60.16 157.70 ± 49.73 53.99 ± 46.46
FAOS
ache
DS (n = 11) 52.00 ± 15.63 69.69 ± 14.41 95.19 ± 5.28 17.68 ± 14.67 − 1.05 (0.294) 43.18 ± 14.36 − 2.35 (0.019) 25.50 ± 11.79 − 3.49 (< 0.001)
Placebo (n = 12) 59.67 ± 11.50 82.63 ± 16.29 89.35 ± 10.51 22.92 ± 14.08 29.64 ± 9.29 6.73 ± 8.16
  1. aMann-Whitney U test